Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82172172)
Science and Technology Bureau of Zhenjiang (SS2023010)
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 7 April 2025
First Online: 14 April 2025
Declarations
:
: Not applicable.
: Cardiovascular diseases (CVDs) remain leading causes of global mortality, with limited therapies available to halt disease progression or reverse tissue damage. Therefore, novel treatments and interventions are urgently needed to address the complex underlying mechanisms. In this review, we explore the structure and biological functions of SG assembly, with a particular focus on its impact on the progression of cardiovascular diseases. We also dicuss potential therapeutic strategies by targeting SGs and their associated signaling pathways. Understanding the potential causal relationship between SGs and various cardiovascular diseases could help identify new targets for developing innovative approaches to CVD treatment.
: The authors declare no competing interests.
